A preliminary study conducted by the Arkansas Children's Research Institute suggests prescription doses of folinic acid could improve the language and communication skills of children with autism spectrum disorder. The study also identified a biomarker that can be used to predict which patients have the best chance to respond to the treatment. The report was published in Springer Nature's journal Molecular Psychiatry and can be read here.